Registrant : Organisation or self-employed individual
| Name/company name: |
Bristol-Myers Squibb Company |
| Acronym: |
B-MS
|
| Legal status: |
Corporation
|
| Website address: |
http://www.bms.com
|
Sections
| Section: |
II - In-house lobbyists and trade/professional associations |
| and more precisely: |
Companies & groups |
Person with legal responsibility
| Surname, Name: |
Mr
Lamberto Andreotti
|
| Position: |
CEO |
Permanent person in charge of EU relations
| Surname, Name: |
Mrs
Anouk De Vroey
|
| Position: |
Sr. Director Policy & Government Affairs Europe |
Contact details:
| Contact details of organisation's head office: |
345 Park Avenue
New York, NY 10154
UNITED STATES
|
| Telephone number: |
(+1) 2125464000 |
| Fax number: |
(+) |
| Other contact information: |
Bristol-Myers Squibb SA, Policy & Government Affairs, Parc de l'Alliance, Avenue de Finlande 4, B-1420 Braine L'Alleud, Belgium - telephone +3223527411 - Fax: +3223527383
|
Goals / remit
| Goals / remit of the organisation: |
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. In 2011, B-MS earned USD 21.2 Billion in revenues and invested USD 3.8 Billion in research & development. Bristol-Myers Squibb has a major presence in Europe.
|
|
The organisation's fields of interests are:
|
|
Number of persons engaged in activities falling under the scope of the Transparency Register
| Number of persons: |
4
|
|
Complementary information:
|
1 Senior Director Policy & Government Affairs Europe (Anouk De Vroey), 1 Associate Director (Jean-Louis Roux), 1 Associate (Athanasia Kanli), 1 Assistant (Nicole Van Elewyck)
|
Persons accredited for access to European Parliament premises
Activities
Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:
|
EUnetHTA, Directive on information to patients, Active and Healthy Ageing innovation partnership
|
Fields of interest for e-mail alerts on consultations and roadmaps;
| Fields declared by the organisation: |
- Competition
- Consumer Affairs
- Customs
- Development
- Economic and Financial Affairs
- Employment and Social Affairs
- Enlargement
- Enterprise
- Environment
- General and Institutional Affairs
- Information Society
- Internal Market
- Public Health
- Research and Technology
- Taxation
- Trade
|
Networking
Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.
|
European Federation of Pharmaceutical Industries and Associations (EFPIA) European Biopharmaceutical Enterprises (EBE), American Chamber of Commerce to the European Union (AmCham EU)
|
Financial data
| Financial year: |
01/2011
-
12/2011
|
|
Estimated costs to the organisation directly related to representing interests to EU institutions in that year:
|
100000
€ - 150000
€
|
|
Amount and source of funding received from the EU institutions in financial year n-1 of registration
|
|
Procurement:
|
0 €
|
|
Grants:
|
0 €
|
Other (financial) information provided by the organisation:
|
This estimate is calcualted on a pro-rata basis of office expenditure and salary costs of BMS staff involved in interest representation to EU institutions, based on proportion of employees' time spent on these activities.
|
|
